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Abstract
Background: Muscle wasting and obesity may complicate the post-stroke trajectory. We investigated the relationships
between nutritional status, body composition, and mobility one to 3 years after stroke.
Methods: Among 279 eligible home-dwelling individuals who had suffered a stroke (except for subarachnoid
bleeding) 1–3 years earlier, 134 (74 ± 5 years, 69 % men) were examined according to the Mini Nutritional
Assessment-Short Form (MNA-SF, 0–14 points), including body mass index (BMI, kg/m2), body composition by
bio-impedance analyses (Tanita BC-545), the Short Physical Performance Battery (SPPB, 0–12 points) combining
walking speed, balance, and chair stand capacity, and the self-reported Physical Activity Scale for the Elderly (PASE).
Results: BMI ≥ 30 kg/m2 was observed in 22 % of cases, and 14 % were at risk for malnutrition according to the
MNA-SF. SPPB scores ≤ 8 in 28 % of cases indicated high risk for disability. Mobility based on the SPPB was not
associated with the fat-free mass index (FFMI) or fat mass index (FMI). Multivariate logistic regression indicated
that low mobility, i.e., SPPB ≤ 8 points, was independently related to risk for malnutrition (OR 4.3, CI 1.7–10.5,
P = 0.02), low physical activity (PASE) (OR 6.5, CI 2.0–21.2, P = 0.02), and high age (OR 0.36, CI 0.15–0.85, P = 0.02).
Sarcopenia, defined as a reduced FFMI combined with SPPB scores≤ 8 or reduced gait speed (<1 m/s), was observed
in 7 % of cases. None of the individuals displayed sarcopenic obesity (SO), defined as sarcopenia with BMI > 30 kg/m2.
Conclusions: Nutritional disorders, i.e., obesity, sarcopenia, or risk for malnutrition, were observed in about one-third
of individuals 1 year after stroke. Risk for malnutrition, self-reported physical activity, and age were related to mobility
(SPPB), whereas fat-free mass (FFM) and fat mass (FM) were not. Nutrition and exercise treatment could be further
evaluated as rehabilitation opportunities after stroke.
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Background
Stroke may affect nutritional status and body compos-
ition by causing eating difficulties and reduced mobility
[1]. Nutrition and stroke are closely linked. On one
hand, obesity and unhealthy eating habits may contrib-
ute to stroke events. On the other hand, post-stroke
weight loss and malnutrition are common with reports
of varying prevalence related to the characteristics of the
examined group [2]. In one study of a cohort of older
stroke individuals, self-reported weight loss of greater
than 3 kg was reported in 26 % 1 year after stroke, and
more severe stroke incidents were associated with
greater weight loss [3]. Poor food and protein intake
may further promote a catabolic state and the progres-
sion towards muscle loss and sarcopenia [4]. Conversely,
approximately half (52 %) of the individuals in the previ-
ously mentioned population-based cohort were over-
weight at the time of the stroke, and 61 % were
overweight after 1 year [3].
Alterations in body composition, such as loss of
muscle mass and increased fat mass (FM), are part of
physiological ageing. Physical inactivity, poor nutrition,
chronic diseases, and hormonal changes may contribute
to altered body composition [5]. Sarcopenia is defined as
the combination of low muscle mass with low muscle
strength and/or function [6]. Individuals who do not re-
gain walking capacity 1 year after stroke display a 6 %
loss of leg lean tissue mass [7]. Depending on the diag-
nostic criteria and the cohort characteristics, the re-
ported prevalence of sarcopenia varies between 1 and
30 % and increases with age in the general population
[8]. Hemiparetic stroke in particular may lead to second-
ary muscle atrophy and specific changes in metabolic
and contractile capacity [9].
The combined state of muscle wasting and obesity is
known as sarcopenic obesity (SO) [9, 10]. The rates of
SO in the elderly are reported to be 2 % and 10 % in
those < 70 years and > 80 years, respectively [9]. Al-
though sarcopenia and SO may complicate the post-
stroke trajectory [6, 11], data on the prevalence of these
conditions after stroke are sparse.
The aims of this study were to determine the physical
function and mobility in relation to nutritional status
and body composition, i.e., obesity, sarcopenia, and SO
in community-dwelling post-stroke individuals one to 3
years after the stroke incident. We hypothesised that
mobility in older individuals who had suffered a stroke
would be related to fat-free mass (FFM), nutritional sta-
tus, and physical activity level.
Methods
Study design and participants
In this cross-sectional cohort study, eligible individuals
were identified by reviewing the national quality
discharge register, i.e., the “Riks-Stroke” register, with
relevance for Uppsala County, Sweden. Participants were
recruited from all stroke patients admitted between
February 2008 and April 2010 who were still alive and
who had been treated at Uppsala University Hospital
during the acute stroke period. Inclusion criteria were as
follows: community-dwelling, 65–85 years of age, and a
verified stroke (cerebral infarction or intracerebral
haemorrhage) within the last one to 3 years. The age
span was chosen to cover the period in life when most
strokes occur and also to exclude patients for whom age
rather than sequelae associated with the stroke may be
the strongest contributor to mobility limitations and sar-
copenia. A flow chart of the inclusion process is pre-
sented in Fig. 1. Exclusion criteria were severe aphasia
or cognitive dysfunction with communication problems.
Individuals with subarachnoid bleeding are not regis-
tered in the national stroke register and were thus not
included.
Procedure
Written study information was sent to the potential
community-living participants 1–3 years after the inci-
dence of stroke. After telephone contact, questionnaires
on nutrition and physical activity during the previous
week were mailed to the participants and completed be-
fore the examination. At the scheduled meeting, after
signing the written consent for participation, blood sam-
ples were drawn. One of the authors (BV) conducted all
examinations. The study procedures adhered to the
Helsinki Declaration. The study was approved by the Re-
gional Ethical Review Board (Dnr 2009:067) of Uppsala
University Hospital, Sweden.
Data collection
Demography, cognition, and morbidity
Age, gender, and co-morbidity data were collected from
patient records and questionnaires. The Charlson Co-
morbidity Index (CCI) was used to classify co-morbid
conditions [12]. Each co-morbid condition was assigned
a weight based on severity and was used to generate a
patient’s total CCI (0–30 points). The original scale in-
cludes cerebrovascular disease and hemiplegia, but these
conditions were not included in the CCI for this study
[13]. Thus, the CCI had a maximum index score of 27
points, with a higher score indicating more severe co-
morbidity. The Short Portable Mental Status Question-
naire (SPMSQ) was used to assess cognition. The
SPMSQ consists of 10 questions with a maximum score
of 10 points [14]. The scale has been tested for acceptable
reliability and validity when administered by telephone
[15]. Some data were obtained from the “Riks-Stroke”
register at the time of stroke, including cardio-vascular
risk factors such as diabetes mellitus, atrial fibrillation,
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hypertension, smoking, and previous stroke or transient
ischaemic attack (TIA). The participants’ need for social
support and information on whether they were living
alone were gathered from the national stroke register at
the 1-year follow-up. Prescribed drugs, including
cholesterol-lowering medications, were recorded at the
examination.
Physical function and activity assessments
Activity limitation was assessed with the Short Physical
Performance Battery (SPPB) [16], which generates a
scale ranging from 0 to 12 points that includes assess-
ments of balance, gait speed, and chair rising. The SPPB
was used to assess performance-based mobility in the
lower extremities. An increasing risk of disability has
been associated with scores ≤ 8 [6]. To assess walking
speed (m/s), the time to perform the 10-m walking test
(10 mWT at a self-selected comfortable pace) was re-
corded using a stop-watch [17]. By converting the 10
mWT (m/s) into 5 subgroups based on walking speed,
we were able to give 0 to 4 points for walking speed
on the SPPB. Score values were as follows: 0 points
(p) = not able to walk, 1 p= ≤ 0.43 m/s, 2 p= 0.44–0.60 m/s,
3 p= 0.61–0.77 m/s, 4 p= ≥ 0.78 m/s [18].
Impairments and activity limitation were also assessed
with the Modified Motor Assessment Scale, Uppsala
University Hospital-99 (M-MAS UAS-99), with a max-
imum score of 55 indicating good overall performance.
This scale is a further development from the original
scale by Carr et al. [19]. The M-MAS UAS-99 includes 8
areas of motor function, transfers, arm and hand func-
tion, and sitting balance. All of the scales have been used
previously in stroke subjects [17, 19, 20] and older indi-
viduals [21]. The reliability and validity of all scales have
been established [17, 19, 21]. The original MAS was
shown to be highly reliable with an inter-rater correl-
ation of 0.95 and an average test-retest correlation of
0.98 [19].
Physical activity was evaluated by the Physical Activity
Scale for the Elderly (PASE), which is designed for the
self-assessment of physical activity over a 1-week period
[22]. The PASE assesses walking, light/moderate or
strenuous sports activities, strength training, activities in
the household or leisure-time activities, and voluntary
work. The scale is scored from 0 upward, with no max-
imum defined score. The type of activity and the associ-
ated frequency and duration were recorded [22]. The
PASE has been validated against accelerometer counts
Fig. 1 Flow chart describing the inclusion process. Abbreviation: BIA = bioelectric impedance analysis
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and an activity diary and has acceptable test-retest reli-
ability (r = 0.68 to 0.84) and validity (in those above age
70 years, r = 0.64) [23]. Moreover, the PASE has shown
moderate correlations with measures of strength, aerobic
activity, and balance in individuals with mild stroke [24].
Nutritional assessment
The Mini Nutritional Assessment-Short Form (MNA-
SF) was used to classify nutritional status [25]. The
MNA-SF consists of six items, including BMI, food in-
take, weight loss, general mobility, acute diseases, psy-
chological stress, and neuropsychological problems [25].
The overall score ranges from 0 to 14 points. Scores of
8–11 points and less than 8 points indicate risk for mal-
nutrition and malnutrition, respectively, whereas scores
of 12–14 points indicate normal nutritional status [25].
The MNA-SF is adapted for older populations [26]. The
patients’ weights were recorded when they were wearing
light indoor clothing. Height was measured to the nearest
cm. We used a BMI < 22 kg/m2 to indicate underweight
because this condition is associated with poor outcomes
in patients ≥ 65 years and in individuals who have suffered
strokes. A BMI between 22 and 24.9 kg/m2 was consid-
ered normal weight. A BMI between 25 and 29.9 kg/m2
was indicative of being overweight, and values ≥ 30 kg/m2
indicated obesity. In addition, an FMI above the 90th per-
centile of a reference population [27] and an FM% above
30 % for women and 20 % for men were registered [28].
Definition of Sarcopenia and Sarcopenic Obesity
Sarcopenia was defined according to the European
Working Group on Sarcopenia in Older People [6]. By
the use of age- and gender-matched reference data from
a group of healthy Swiss adults (2,986 men and 2,649
women) sarcopenia was defined as fat-free mass index
(FFMI) below the 25th percentile [27] combined with ei-
ther an SPPB score ≤ 8 or comfortable gait speed <
1.0 m/s [6]. SO was defined as the combination of sarco-
penia (according to the mentioned formula) and BMI >
30 kg/m2 [9, 29].
Body composition assessments
Bioelectrical impedance analysis (BIA) was performed
with a Tanita BC-545 Body Composition Analyzer
(Tanita, Inc., Tokyo, Japan). Measurements were per-
formed with the individual in the standing position. The
device provides measurements of FFM in kilograms and
percentage of total body fat (FM%) according to the
equation provided by the software of the machine. The
FM index (FMI, kg/m2) was calculated as the FM (kg)
divided by the height (m) squared. The fat-free mass
index (FFMI) (kg/m2) was calculated by subtracting the
FMI (kg/m2) from the BMI (kg/ m2). A BIA device (The
BC-418 8-contact electrode system (Tanita Corp, Tokyo,
Japan) similar to the one used in this study and measur-
ing the subjects in standing position has been validated
against dual-energy X-ray absorptiometry (DEXA) and
showed good correlations for muscle mass (r = 0.99) and
FM (r = 0.87) [30].
Biochemical analyses
Non-fasting venous blood samples were obtained, and
the biochemical analyses were performed according to
the methods of the Department of Clinical Chemistry at
the Uppsala Akademiska University Hospital. The sam-
ples were frozen at −70 °C until analysis. The biochem-
ical variables included total cholesterol, low-density
lipoprotein (LDL) cholesterol, high-density lipoprotein
(HDL) cholesterol, plasma albumin, serum insulin-like
growth factor-I (IGF-I), and C-reactive protein (CRP).
The serum lipid concentrations were considered patho-
logical when the total cholesterol was > 5 mmol/l, LDL
cholesterol ≥ 3.0 mmol/l, and HDL cholesterol <
1.2 mmol/l in women and < 1.1 mmol/l in men. The
plasma albumin reference value was 34–45 g/l, and the
IGF-1 reference value for individuals aged 71–75 years
was 64–188 μg/l. A CRP level > 5 mg/l was considered
to indicate on-going inflammation.
Statistical analysis
Descriptive analyses were performed according to the
type and distribution of the variables. The differences
between men and women and between age classes of
65–74 and 75–85 years were assessed using Student’s t-
test for continuous, normally distributed variables and
the Mann Whitney U-test for ordinal variables. Categor-
ical variables were compared using Pearson’s chi-
squared test (χ2), and for non-normal distributed data,
Spearman’s rank-order correlation test was used. The
significance level was set at p < 0.05.
Regression analyses
Odds ratios (ORs) and 95 % confidence intervals (CIs)
for low versus high mobility, with SPPB as the
dependent variable, were calculated to determine inde-
pendent covariates using multiple logistic regression
models. Univariate analyses were conducted to deter-
mine significantly associated covariates with mobility
(SPPB) and were subsequently tested for multi-
collinearity by cross-tabulation. The Statistical Package
for the Social Sciences (SPSS), version 23, was used for
the analyses (SPSS Inc., Chicago, IL, USA).
Results
Table 1 presents the baseline characteristics of the 134
participants. A median of 13 months (range: 12 to
38 months) had elapsed between the stroke event and
the post-stroke examination.
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Two-thirds of the participants were men, and all
were Caucasian. The gender distribution and age were
the same among the eligible subjects who did not par-
ticipate in the study for various reasons (Fig. 1). Cognitive
function (SPMSQ) was high; 71 % of the participants had
the highest possible score. Among the 61 participants who
could not undergo BIA, the gender distribution (74 %
males) and age (75 [5.0] years) were similar, whereas the
SPPB score (median of 8 points) was reduced (p < 0.001)
and the co-morbidity rate was higher (p = 0.025) com-
pared with those who underwent BIA.
Data on nutritional status, physical function, body com-
position, and bio-chemical variables are presented in
Table 2. Although MNA-SF indicated a normal nutritional
status in general, 14 % were considered at risk for malnutri-
tion. None were malnourished. Overweight was observed
in 48 %, and obesity (BMI ≥ 30 kg/m2) was observed in
22 % of the subjects.
All participants were able to walk outside according to
the mobility item of the MNA-SF questionnaire. A
reduced SPPB (≤8 p) was observed in 28 %, with the
highest occurrence in old women (Table 2). A low gait
speed (<1 m/s) was observed in 28 %, with the highest
occurrence in older women (Table 2). FMIs above the
90th percentile of a Swiss reference population [27] were
observed in 26 %, and 87 % of the individuals had FM%
values above the reference value. FFMI was low (defined
as < 25th percentile of a Swiss reference population) in
14 % of the individuals [27]. Sarcopenia, i.e., the combined
finding of reduced FFMI with either low SPPB (≤8 points)
or low gait speed (<1.0 m/s), was observed in 7 %. None
of these sarcopenic individuals were also obese; thus, SO
was not observed [9, 29].
The levels of physical activity (PASE) ranged from 0–312
points, with no significant difference between men and
women. Motor function was generally high; 67 % of
the individuals reached the maximum of 55 points in
the M-MAS UAS-99 (range 39–55). This indicates that
the stroke population in this study only had minor to
moderate impairments and activity restrictions.
Next, we analysed potential denominators of mobility
(SPPB). The co-variates were selected from measures of
body composition, nutritional status, and physical activity
(PASE and M-MAS). For the correlation and regression
analyses between SPPB and MNA-SF, the “mobility” item
was removed from the MNA-SF to avoid multicollinearity.
For this analysis MNA-SF 11–12 points indicated normal
nutritional status, whereas scores of ≤ 10 indicated risk for
malnutrition, and this cut-off was used to dichotomise
nutritional status. Considering all individuals, univariate
analysis revealed significant associations between SPPB
and age (r = −0.33, P = 0.044), PASE (r = 0.51, P < 0.001),
nutritional status (MNA-SF without the “mobility” item)
(r = 0.33, P < 0.001), and gender (r = 0.17, P = 0.054).
Gender-separated associations are presented in Table 3.
There were no univariate associations between SPPB
and any body composition measure including FFMI
in either the whole group or when separated by gen-
der. The M-MAS showed a ceiling effect and was
therefore not used in the multivariate regression
analyses.
We used the cut-off of ≤ 8 points to dichotomise mobil-
ity into high and low mobility [6] for logistic regression
analyses. All estimates were adjusted for age (65–74 and
75–85 years) and gender. When the remaining variables
were tested for multi-collinearity by cross-tabulation, the
PASE scores (divided into tertiles indicating low, medium,
and high physical activity), nutritional status, age (10-year
intervals), and gender were selected as independent vari-
ables in the regression analyses with SPPB as the
dependent variable. Table 4 shows the result of the
univariate and the adjusted multivariate logistic re-
gression analyses, indicating that low mobility was re-
lated to the risk of malnutrition (MNA-SF, OR 4.3, CI
Table 1 Characteristics of the included participants (n = 134)
At examination
Age, years, mean (SD) 74 (7)
Male, n (%) 93 (69)
Living alone, n (%) 35 (26)
Social support, n (%)
Yes, partial 36 (27)
Yes, complete 11 (8)
At stroke
Stroke characteristics, n (%)
Cerebral infarction 117 (87)
Intra-cerebral haemorrhage 17 (13)






Risk factors for stroke, n (%)
Earlier stroke 27 (21)
Transient Ischemic Attack 13 (10)
Diabetes 20 (16)
Atrial fibrillation 28 (22)
Hypertension 82 (65)
Smoking 18 (14)
SPMSQ, (0–10 p), median (IQR) 10 (1)
Data were collected from the RIKS-Stroke Register and medical records
Abbreviations: CCI Charlson comorbidity index based on weighted conditions,
0–27, SPMSQ Short Portable Mentale Status Questionnaire
Vahlberg et al. BMC Geriatrics  (2016) 16:48 Page 5 of 9
1.7–10.5), low physical activity (PASE) (OR 6.5, CI
2.0–21.2), medium physical activity (PASE) (OR 3.5,
CI 1.3–9.6) and, finally, every 10 years of increased
age (OR 0.36, CI 0.15–0.85).
Interestingly, when the individual components of SPPB
were tested for potential univariate associations, time for
five chair-stands (s) revealed significant associations with
physical activity (r = −0.35, P > 0.001), nutritional status
(r = −0.22, P = 0.012), and FMI (r = 0.21, P = 0.017).
Discussion
This study on ambulatory community-dwelling individ-
uals one to 3 years after stroke displayed some confirma-
tive and some novel findings. Not surprisingly, more
than one in five individuals were obese. Reduced mobil-
ity (SPPB) and low gait speed in 29 % and 28 %, respect-
ively, was also expected. The prevalence of sarcopenia
was approximately 7 % according to the used definition.
None of the individuals had SO. Fourteen percent of the
Table 2 Nutritional status body composition, physical function and bio-chemical status, 1–3 years after stroke
Men Women
Total 65–74 years 75–85 years 65–74 years 75–85 years Gender difference
(n = 134) (n = 54) (n = 39) (n = 23) (n = 18) P-value
MNA-SF (0–14 p), median (IQR)a 14 (2) 14 (1) 13 (2) 13 (2) 13.5 (2) 0.24
BMI (kg/m2), mean (SD) 27.3 (4.1) 27.8 (4.0) 26.4 (2.8) 27.4 (4.8) 27 (5.4) 0.68
BMI class, (kg/m2), n (%)
< 22 8 (6) 3 (5.6) 1 (2.6) 2 (8.7) 2 (11.1) NA
22–24.9 31 (23.3) 11 (20.4) 12 (31.6) 5 (21.7) 3 (16.7) 0.62
25–29.9 64 (48.1) 24 (44.4) 20 (52.6) 12 (52.2) 8 (44.4) 0.17
≥ 30 30 (22.6) 16 (29.6) 5 (13.2) 4 (17.4) 5 (27.8) 0.41
10 mWT (m/s), mean (SD) 1.08 (0.25) 1.16 (0.25) 1.10 (0.22) 0.96 (0.23) 0.94 (0.23) >0.001
<1.0 m/s, n (%) 38 (28) 11 (12) 7 (7) 11 (27) 9 (2)
SPPB (0–12 p), median (IQR) 10 (3) 11 (16) 10 (4) 10 (3) 9 (4) 0.005
≤ 8, n (%) 37 (41) 15 (16) 19 (20) 10 (24) 11 (27)
PASE, (0 ≤ p), mean (SD) 108 (65) 121 (101) 104 (73) 98 (52) 95 (50) 0.18
FFM (kg), mean (SD) <0.001
Male, mean (SD) 58.5 (6.9) 59.5 (7.4) 56.4 (5.7)
Female, mean (SD) 41.9 (5.3) 42.4 (4.8) 41.3 (5.9)
FFMI (kg/m2), median (IQR) <0.001
Male, median (IQR) 19.4 (2.2) 19.5 (2.4) 19.3 (2.3)
Female, median (IQR) 16.7 (1.5) 16.7 (2.3) 16.7 (2.8)
FMI (kg/m2), median (IQR) <0.001
Male, median (IQR) 7.3 (3.0) 7.8 (3.2) 7.0 (3.1)
Female, median (IQR) 10.1 (3.6) 10.1 (3.0) 9.9 (4.6)
FM%, mean (SD) <0.001
Male, mean (SD) 27.2 (5.3) 28.0 (5.4) 26.3 (5.2)
Female, mean (SD) 38.0 (6.3) 37.7 (6.6) 38.4 (6.1)
Plasma total cholesterol, (mmol/l), mean (SD) 4.9 (1.0) 4.7 (0.94) 4.6 (0.93) 5.4 (1.3) 5.2 (0.93) 0.007
Plasma LDL cholesterol, (mmol/l), mean (SD) 2.5 (0.75) 2.5 (0.78) 2.3 (0.65) 2.6 (0.88) 2.6 (0.69) 0.18
Plasma HDL cholesterol, (mmol/l), mean (SD) 1.4 (0.33) 1.2 (0.25) 1.3 (0.38) 1.5 (0.50) 1.5 (0.29) <0.001
Plasma albumin (g/l), mean (SD) 38.1 (2.7) 38.6 (2.7) 37.4 (2.5) 38.4 (3.0) 37.2 (2.4) 0.39
Serum IGF-I*, μg/l, mean (SD) 131.1 (46.6) 131.5 (44.9) 134.0 (44.0) 131.8 (56.3) 120.6 (44.7) 0.52
Plasma CRP, mg/l, median (IQR) 1.9 (2.7) 1.9 (2.3) 2.6 (2.3) 1.4 (3.7) 2.3 (2.9) 0.55
Data are means (SD) or medians (IQR). aReference values for FM%: <20 % (men) or <30 % (women)
Abbreviations: BMI Body Mass Index, CRP C-Reactive Protein, FM Fat Mass, FMI Fat Mass Index, FFM Fat-Free Mass, FFMI Fat-Free Mass Index, HDL High Density
Lipoprotein, LDL Low Density Lipoprotein, MNA-SF Mini Nutritional Assessment - Short Form, NA Non-applicant, PASE Physical Activity Scale for the Elderly, S-IGF-I
Insulin-Like Growth Factor-I, SPPB Short Physical Performance Battery, 10 mWT 10-m Walking Test. P < 0.05
aFor this analysis MNA-SF was calculated with the mobility item omitted
* the IGF-1 reference value for individuals aged 71–75 years was 64–188 μg/l
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individuals were identified as at risk for malnutrition,
whereas none were classified as malnourished. The risk
of malnutrition according to the MNA-SF, old age, and
reduced levels of self-reported physical activity (PASE)
were associated with an exponential risk for low mobility
(SPPB). A somewhat unexpected result was that body
composition measures (e.g., FMI and FFMI) were not
related to SPPB scores. Therefore, the hypothesis that
reduced FFMI was associated with reduced mobility
could not be confirmed. However, the other hypotheses
concerning the associations of the SPPB with nutritional
status and self-reported physical activity were confirmed.
The prevalence of sarcopenia was unexpectedly low
(7 %) in this cohort of post-stroke subjects and is gener-
ally in line with findings in community-dwelling older
individuals [6]. The observed low prevalence is mainly
related to the apparently well-preserved muscle mass of
the subjects, as they appeared to have an even greater
muscle mass than the Swiss healthy reference popula-
tion. This finding is difficult to explain, but it may relate
to the fact that the weight was higher in the post-stroke
cohort and that obesity was common, which is known to
be related to higher muscle mass [31, 32]. It is also im-
portant to realise that most of the included individuals
in this study had suffered a minor stroke without a
pronounced hemiparesis and with preserved walking
capacity. In Sweden, 74 % of stroke patients are released
to their home after acute stroke. This fact indicates that
the current study is fairly representative of community-
dwelling post-stroke individuals. There is a stroke-
specific type of sarcopenia [31, 32] that primarily occurs
in patients with more severe disease than observed
among these study participants. To our knowledge, this
is the first report on the prevalence of sarcopenia in
community-dwelling individuals after stroke.
The patients’ diet histories were not recorded; thus, it
is difficult to establish whether a high energy intake or
physical inactivity was the major cause for obesity. Des-
pite inconsistent findings, whole-body FM appears to in-
crease between 6 and 12 months post-stroke, whereas
no change in FFM has been reported over time [33, 34].
Interestingly, recent studies have reported lower mortal-
ity, improved functional outcomes, and a lower risk for
re-admission from recurrent stroke in obese compared
with lean stroke patients [31, 35]. This is sometimes re-
ferred to as the obesity paradox [35].
The prevalence of malnutrition or being at risk for
malnutrition (14 %) according to MNA-SF in the present
study was lower than the corresponding 37 % reported
from a European compilation of community-living older
adults (age 79 years) without stroke [36]. Although the
mean age was 5 years lower in the current study group
of post-stroke community-living individuals, the com-
bined findings indicate that the study group was in fairly
good condition.
As illustrated by the M-MAS UAS-99 results, motor
function was high. If more disabled individuals had been
included, the prevalence rates of sarcopenia and SO
would likely have been higher. The observation of over-
weight and obesity not being associated with reduced
mobility was interesting and somewhat unexpected and
contrasted with earlier findings [9]. As already indicated,
it was also unexpected that alterations in FFMI were not
related to mobility as measured by the SPPB. This result
suggests that muscle mass is not always crucial for
Table 3 Univariate associations between mobility (SPPB) and
age, body composition, physical activity level and nutritional
status, 1–3 years after stroke
Women (n = 41) Men (n = 93)
Explanatory variables r P r P
Age, years −0.29 0.065 −0.31 0.003
FFMI, (kg/m2) 0.015 0.89 −0.033 0.83
FMI, (kg/m2) −0.012 0.94 −0.046 0.66
PASE (points, ≥0) 0.45 0.003 0.5 <0.001
MNA-SF 0.32 0.039 0.31 0.003
Abbreviations: SPPB Short Physical Performance Battery, Fat Mass, FMI Fat-Free
Mass, FFMI MNA-SF Mini Nutritional Assessment - Short Form, PASE Physical
Activity Scale for the Elderly
P < 0.05
Table 4 Logistic regression with low mobility (SPPB) as dependent variable in 134 cases, 1–3 years after stroke
Univariate model Multivariate model
Odds ratio 95 % CI P Odds ratio 95 % CI P
Explanatory variables
PASE medium level 3.3 1.3 to 8.1 0.012 3.5 1.3 to 9.6 0.013
PASE low level 7.7 2.6 to 22.9 <0.001 6.5 2.0 to 21.2 0.02
MNA-SF (except mobility)a 4.3 1.9 to 9.8 <0.001 4.3 1.7 to 10.5 0.02
Gender 1.3 0.58 to 2.99 0.48 1.13 0.83 to 0.98 0.79
Age per 10 years 0.38 0.18 to 0.81 0.013 0.36 0.15 to 0.85 0.02
Analyses were adjusted for gender and age (per 10-year increment), R2 = Chi-square (χ2) = 13.8, p = 0.087 (Hosmer & Lemeshow)
Abbreviations: MNA-SF Mini Nutritional Assessment-Short Form, PASE Physical Activity
Scale for the Elderly (PASE; medium vs. high and low vs. high)
a For this analysis MNA-SF was calculated with the mobility item omitted”
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function, which has also been observed in other studies
performed in elderly populations [32, 37]. Perhaps this
lack of relationship between muscle mass and function
is even more pronounced in stroke survivors for whom
neurological damage also contributes to strength and
function.
The reduced PASE scores recorded in the current
study are in agreement with previous reports of
community-living individuals with stroke, corresponding
to 67 % of gender- and age-matched control values [38].
It is unlikely that the observed reduced mobility and
physical activity were primarily related to neurological
damage due to the previous stroke because only a few
individuals had motor impairments.
The current study has limitations that need to be ac-
knowledged. About half of the eligible population could
not be examined, which may limit the generalisability of
the results. Individuals with more severe disabilities (e.g.,
unable to stand safely) could not perform the BIA pro-
cedure, which affects the generalisation of the results to
more disabled stroke patients, e.g., nursing-home resi-
dents. Individuals in the Swiss reference population con-
ducted BIA in the supine position. In the current study
BIA was performed in standing position, which may dif-
fer from BIA measurement performed in lying. Further-
more, individuals with subarachnoid haemorrhage were
not included. All individuals in this study were
community-dwelling, indicating better functional and
nutritional status compared with nursing home resi-
dents. According to the International Classification of
Functioning Disability and Health (ICF), disability is an
umbrella term for impairments, activity limitations, and
participation restrictions [39]. The measures of this
study covered a great part of the ICF description of dis-
ability by including the motor function (M-MAS UAS-
99), mobility (SPPB), and gait speed (10 mWT). Activity
limitations and to some extent also participation restric-
tions were covered by the PASE, measuring exercise,
leisure-time activities and voluntary work. Moreover, the
cross-sectional design of the study limits the possibility
to make causal inferences. Further studies on body com-
position and sarcopenia in stroke populations with
minor to moderate stroke are needed [34].
Conclusions
We conclude that in community-living subjects assessed
one to 3 years after stroke, reduced mobility according
to SPPB was related to risks of malnutrition (according
to the MNA-SF), low and medium physical activity
(according to PASE) but not to alterations in body com-
position, e.g., FFMI and FMI. Obesity, sarcopenia, and
risk of malnutrition were observed in about one-third of
the study population. These results suggest that stroke
rehabilitation efforts could benefit from promoting a
healthy and nutritious diet and physical activity to opti-
mise mobility, reduce obesity, and avoid sarcopenia.
Intervention studies are needed to address the potential
benefits of such lifestyle changes.
Abbreviations
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